Skip to content

Clinical trials

Phase 3 Cognitive Dysfunction trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Phase: Phase 3 Country / region: Germany Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20061
20092
20131
20141
20161
20191
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated4
Active, not recruiting3
Completed2
Recruiting2
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb2
Hoffmann-La Roche2
M. Schaefer, MD2
University Hospital Muenster2
Charite University, Berlin, Germany1
Eisai Co., Ltd.1
Eisai Inc.1
European Group for Research In Schizophrenia1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
TauRx Therapeutics Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction14
Alzheimer Disease8
Dementia5
Schizophrenia3
Brain Diseases1
Fatigue1
Frontotemporal Dementia1
Mental Disorders1
Neoplasms1
Nervous System Diseases1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.